1. "Gynecologic Medicine Service"
Formats
  1. Journal Article (1087)
  2. Meeting Abstract (890)
  3. Review (52)
  4. Book Section (46)
  5. Editorial (35)
  6. Guidelines (21)
  7. Correspondence (9)
  8. Miscellaneous (3)
  9. Research Letter (2)
  10. Book Whole (1)
Groups
  1. Gynecologic Medicine Service (2146)
  2. Solid Tumor Oncology Division (2146)
  3. Department of Medicine (2142)
  4. Gynecology Disease Management Team (1846)
  5. GDMT, Medicine (1828)
  6. Surgery (594)

More Groups

People
  1. Carol Aghajanian (607)
  2. Martee Hensley (289)
  3. Nadeem Abu-Rustum (288)
  4. Roisin O'Cearbhaill (271)
  5. Vicky Makker (263)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (41)
  2. 2024 (167)
  3. 2023 (171)
  4. 2022 (209)
  5. 2021 (163)
  6. 2020 (203)

More Years

Publications
  1. Journal of Clinical Oncology (450)
  2. Gynecologic Oncology (418)
  3. International Journal of Gynecological Cancer (154)
  4. Annals of Oncology (116)
  5. Clinical Cancer Research (67)
  6. Cancer Research (55)

More Publications

Publishers
  1. Elsevier Inc. (542)
  2. American Society of Clinical Oncology (489)
  3. Lippincott Williams & Wilkins (181)
  4. American Association for Cancer Research (168)
  5. Oxford University Press (143)
  6. Nature Publishing Group (86)

More Publishers

Results (2146)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A randomized phase III trial of durvalumab with chemotherapy and bevacizumab, followed by maintenance durvalumab, bevacizumab and olaparib in newly diagnosed advanced ovarian cancer (DUO-O): Updated trial endpoint and inclusion of China cohort
    Meeting Abstract

    Okamoto, A.; Kim, J. W.; Yin, R.; Trillsch, F.; Reuss, A.; Aghajanian, C.; Rubio-Pérez, M. J.; Vardar, M. A.; Scambia, G.; Floquet, A.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Ten-year conditional probability of survival for patients with ovarian cancer: A new metric for the new millennium
    Meeting Abstract

    Kahn, R.; Filippova, O.; Straubhar, A.; An, A.; Zivanovic, O.; Gardner, G.; O'Cearbhaill, R.; Tew, W.; Sonoda, Y.; Roche, K. L.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Molecular and pathologic data can guide selection of endometrioid endometrial cancer patients for ovarian preservation
    Meeting Abstract

    Manning-Geist, B.; Rios-Doria, E.; Liu, Y.; Ellenson, L.; Zhou, Q.; Leitao, M.; Abu-Rustum, N.; Weigelt, B.; Mueller, J.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Prognosis of isolated tumor cells and the utility of molecular classification in early stage endometrioid endometrial cancer
    Meeting Abstract

    Rios-Doria, E.; Abu-Rustum, N.; Alektiar, K.; Makker, V.; Liu, Y.; Zamarin, D.; Friedman, C.; Aghajanian, C.; Ellenson, L.; Weigelt, B.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • A preoperative tool for estimating the risk of blood transfusion over an ovarian cancer debulking surgery
    Meeting Abstract

    Kahn, R.; Boerner, T.; An, A.; Gardner, G.; Roche, K. L.; Sonoda, Y.; Zivanovic, O.; Grisham, R.; Abu-Rustum, N.; Chi, D.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Outcomes after recurrence of low-grade endometrial stromal sarcoma (LGESS)
    Meeting Abstract

    Miller, K.; Smith, E.; Sonoda, Y.; Mueller, J.; Alektiar, A.; Makker, V.; Hensley, M.; Abu-Rustum, N.; Leitao, M.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Molecular classification of endometrial carcinomas: A single-institution review
    Meeting Abstract

    Rios-Doria, E.; Abu-Rustum, N.; Leitao, M.; Alektiar, K.; Makker, V.; Liu, Y.; Zamarin, D.; Friedman, C.; Aghajanian, C.; Ellenson, L.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Predicting outcomes in female germ cell patients using a modified International Germ Cell Cancer Collaborative Group classification system to guide management
    Meeting Abstract

    Manning-Geist, B.; Deng, L.; Knezevic, A.; Bromberg, M.; Funt, S.; Zivanovic, O.; Roche, K. L.; Sonoda, Y.; Gardner, G.; Grisham, R.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • LIO-1: Initial phase 2 experience of lucitanib + nivolumab in patients with metastatic or recurrent cervical cancer (NCT04042116; ENGOT-GYN3/AGO/LIO)
    Meeting Abstract

    Oaknin, A.; Backes, F.; Van Nieuwenhuysen, E.; Eskander, R.; González-Martín, A.; Makker, V.; Marth, C.; Patel, M.; Penson, R.; Redondo, A.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Safety and immunogenicity of anti PD-L1 (atezolizumab) given as an immune primer or concurrently with extended field chemoradiotherapy for node positive locally advanced cervical cancer: An NRG oncology trial
    Meeting Abstract

    Mayadev, J.; Zamarin, D.; Deng, W.; Lankes, H.; Pesci, G.; Park, K.; Banbury, B.; Sherry, N.; Ghamande, S.; Holman, L.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save